Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07405294 · ClinicalTrials.gov registry record
TeleMAb Retrospective Cohort Study
A clinical trial of Telemedicine and Medication Abortion, sponsored by Columbia University.
- Active
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT07405294: Active study of Telemedicine and Medication Abortion, sponsored by Columbia University.
NCT07405294 is a study of Telemedicine and Medication Abortion that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 400 participants, below the 4,035-participant average among 18 other Telemedicine trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07405294, a study of Telemedicine and Medication Abortion, is active but no longer recruiting, sponsored by Columbia University.
- ACTIVE NOT RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.
Primary Outcome
If patients engaged in follow-up are outside of their routinely scheduled follow-up visit 1-2 weeks after medication abortion
Conditions Studied
Interventions
- OTHER Telemedicine Medication Abortion
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2026-07-31 |
What the registry record for NCT07405294 still lists
NCT07405294 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 4,035-participant average among 18 other Telemedicine trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Telemedicine appearing as the primary indexed condition, and to 1 intervention - of which Telemedicine Medication Abortion is the first listed.
NCT07405294 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07405294 about?
NCT07405294 is a clinical study titled "TeleMAb Retrospective Cohort Study". The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unschedul...
What is the current status of trial NCT07405294?
This trial is currently active not recruiting. The enrollment target is 400 participants. The study started on 2023-06-12. Estimated completion is 2026-07-31.
What conditions does trial NCT07405294 study?
This clinical trial studies the following conditions: Telemedicine, Medication Abortion.
What interventions are being tested in trial NCT07405294?
The interventions under investigation include: Telemedicine Medication Abortion (OTHER).
Who is sponsoring clinical trial NCT07405294?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07405294 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Telemedicine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07405294's enrollment target sits among peer trials
400 10th of 18 higher than 9 of 18 other Telemedicine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Telemedicine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
-
Integrating Telehealth to Advance Lung Cancer Screening
RECRUITING · NA
-
Integrated Telemedicine Program Evaluation
RECRUITING · NA
-
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors
RECRUITING · NA
-
The Actuate-CBC Study
RECRUITING
-
Telehealth-delivered HealthcaRe to ImproVe Care
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI